OncoSil Medical Health Care
Cancer Health Care

$0.012 (0%)

High $0.01	Low $0.01	Trades 21	Turnover $70,215	Volume 5,851,219
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code OSL	Name Oncosil Medical Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Life Sciences Tools & Services	GIC Sub Industry Life Sciences Tools & Services
Sector Healthcare	IPO Date 2005-08-15	Fiscal Year June	Type Common Stock
Shares Outstanding 30,890,478	Shares Floated 15,284,744	Held by Insiders 9.865%	Held by Institutions 38.774%

Directors & Officers

Name & Education	Position
Mr. Nigel Lange	CEO, MD & Director
Ms. Shelley Steyn	Chief Financial Officer
Mr. David Turner	Head of Medical Affairs
Prof. Jon Bell	Chief Medical Officer
Mr. Henk Tissing	Global Head of Clinical Affairs
Mr. Renzo DiCarlo	Head of Transformation
Mr. Timothy Luscombe B.Com., C.A.	Company Secretary
Ms. Nova Anne Taylor	Joint Company Secretary

OSL Historic Dividends

Date	Amount
We found no dividends on record for OSL.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$1.16	88,095	+0.05 (4.50%)
30-Jul	$1.11	105,176	0.00 (0.00%)
29-Jul	$1.11	170,151	+0.08 (7.77%)
28-Jul	$1.03	503,639	-0.14 (11.97%)
27-Jul	$1.17	93,619	-0.04 (2.90%)
24-Jul	$1.21	94,247	-0.10 (7.31%)
23-Jul	$1.30	198,828	+0.15 (13.04%)
22-Jul	$1.15	219,640	-0.11 (8.73%)
21-Jul	$1.26	136,903	-0.04 (3.08%)
20-Jul	$1.30	322,371	-0.15 (10.34%)
17-Jul	$1.45	162,292	-0.45 (23.68%)
18-Sep	$1.90	183,602	+0.23 (13.43%)
12-Sep	$1.68	8,392	-0.04 (2.33%)
11-Sep	$1.72	19,734	+0.51 (41.74%)
05-Sep	$1.21	23,187	+0.10 (8.52%)
6 up, 8 down, and 1 flat days

Market Cap (31-Jul) $35,832,952	EBITDA -	PE 4.51	Book Value $0.20
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.94	Profit Margin N/A
Operating Margin -143.95%	ROA 87.11%	ROE 208.41%	Revenue (FY) $3,724,932
Revenue per Share $0.24	Gross Profit (FY) $1,073,871	Q' YOY Revenue Growth 222.2%	Q' YOY Earnings Growth -

OncoSil Medical Health Care
Cancer Health Care

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

OSL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

OncoSil Medical Health Care Cancer Health Care

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

OSL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

OncoSil Medical Health Care
Cancer Health Care